DELTA & PINE LAND CO
10-Q, 2000-07-17
AGRICULTURAL PRODUCTION-CROPS
Previous: INVESTMENT COUNSELORS INC, 13F-HR, 2000-07-17
Next: DELTA & PINE LAND CO, 10-Q, EX-27, 2000-07-17



                                  UNITED STATES

                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                                    FORM 10-Q

(x)  Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange
     Act of 1934 For the quarterly period ended May 31, 2000 or

( )  Transition  Report  Pursuant  to Section  13 or 15(d) of the  Securities
     Exchange    Act   of   1934   For   the    transition    period   from
     _________________ to  __________________


                        Commission File Number: 000-21788

              Exact name of registrant as specified in its charter:
                           DELTA AND PINE LAND COMPANY

                        State of Incorporation: Delaware
                I.R.S. Employer Identification Number: 62-1040440

           Address of Principal Executive Offices (including zip code)
                    One Cotton Row, Scott, Mississippi 38772

               Registrant's telephone number, including area code:
                                 (662) 742-4500


Indicate by check mark whether  Registrant (1) has filed all reports required to
be filed by Section 13 or 15(d) of the  Securities  Exchange  Act of 1934 during
the  preceding 12 months (or for such  shorter  period that the  registrant  was
required  to file  such  reports)  and  (2)  has  been  subject  to such  filing
requirements for the past 90 days.

YES (x)    NO ( )

                      APPLICABLE ONLY TO CORPORATE ISSUERS:

Indicate the number of shares  outstanding  of each of the  issuer's  classes of
common stock, as of the latest practicable date.

Common Stock, $0.10 Par Value 38,351,501 shares outstanding as of May 31, 2000.


<PAGE>


                  DELTA AND PINE LAND COMPANY AND SUBSIDIARIES

                                      INDEX

PART I. FINANCIAL INFORMATION                                           Page No.

Item 1. Consolidated Financial Statements

Consolidated Balance Sheets - May 31, 1999,
     August 31, 1999, and May 31, 2000                                         4

Consolidated Statements of Operations - Three Months
     Ended May 31, 1999 and May 31, 2000                                       5

Consolidated Statements of Operations - Nine Months
     Ended May 31, 1999 and May 31, 2000                                       6

Consolidated Statements of Cash Flows - Nine Months
     Ended May 31, 1999 and May 31, 2000                                       7

Notes to Consolidated Financial Statements                                8 - 15

Item 2. Management's Discussion and Analysis of Financial
           Condition and Results of Operations                                15

PART II.  OTHER INFORMATION

     Item 1.   Legal Proceedings                                              18
     Item 4.   Submission of Matters to a Vote of Security Holders            18
     Item 5.   Business                                                       18
     Item 6.   Exhibits and Reports on Form 8-K                               24
                   Signatures                                                 25


<PAGE>


PART I. FINANCIAL INFORMATION
Item 1. Consolidated Financial Statements
<TABLE>
<CAPTION>

                  DELTA AND PINE LAND COMPANY AND SUBSIDIARIES
                          CONSOLIDATED BALANCE SHEETS
               (in thousands, except share and per share amounts)
                                  (Unaudited)


                                                                                May 31,                August 31,            May 31,
                                                                                1999                    1999                  2000
                                                                                ----                    ----                  ----
<S>                                                                             <C>                     <C>                     <C>
ASSETS
CURRENT ASSETS:
Cash and cash equivalents                                              $       6,658          $       7,552            $      61,845
Receivables, net                                                             236,495                147,926                  260,376
Inventories                                                                   70,931                 47,727                   47,276
Prepaid expenses                                                               3,533                  1,473                    1,666
Deferred income taxes                                                          4,408                 12,865                   13,070
                                                                       -------------          -------------            -------------
    Total current assets                                                     322,025                217,543                  384,233
                                                                       -------------          -------------            -------------
PROPERTY, PLANT and EQUIPMENT, net                                            65,587                 65,166                   64,001
EXCESS OF COST OVER NET ASSETS OF
BUSINESS ACQUIRED, net                                                         4,488                  4,458                    4,559
INTANGIBLES, net                                                               4,479                  4,365                    4,296
OTHER ASSETS                                                                   2,898                  4,226                    2,961
                                                                       -------------          -------------            -------------
                                                                       $     399,477          $     295,758             $    460,050
                                                                       =============          =============             ============
LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES:
    Notes payable                                                      $      15,055          $       3,819            $      1,001
    Accounts payable                                                          16,780                 19,990                  15,370
    Accrued expenses                                                         191,120                143,352                 213,054
    Income taxes payable                                                      10,492                  8,082                  51,067
                                                                       -------------          -------------            -------------
        Total current liabilities                                            233,447                175,243                 280,492
                                                                       -------------          -------------            -------------
LONG-TERM DEBT, less current maturities                                       55,003                 17,000                     189
                                                                       -------------          -------------            -------------
DEFERRED INCOME TAXES                                                          5,020                  5,773                   5,774
                                                                       -------------          -------------            -------------
MINORITY INTEREST IN SUBSIDIARIES                                              9,098                  8,338                   8,620
                                                                       -------------          -------------            -------------
STOCKHOLDERS' EQUITY:
Preferred  stock,  par  value $0.10 per share; 2,000,000 shares authorized:
   Series A Junior Participating Preferred, par value $0.10 per share;
   429,319 shares authorized; no shares issued or outstanding
                                                                                   -                      -                       -
   Series M Convertible Non-Voting Preferred,   par value  $0.10 per
   share; 1,066,666 shares authorized, issued, and outstanding                   107                    107                     107

Common stock, par value $0.10 per share;
   100,000,000 shares authorized; 38,584,700; 38,664,565 and
   38,919,467 shares issued; 38,470,434; 38,550,299 and 38,351,501
   shares outstanding                                                          3,859                  3,866                   3,891
Capital in excess of par value                                                38,123                 41,179                  44,609
Retained earnings                                                             59,293                 48,970                 129,415
Accumulated other comprehensive loss                                          (2,300)                (2,545)                 (3,171)
Treasury Stock at cost, 114,266; 114,266 and 567,966 shares                   (2,173)                (2,173)                 (9,876)
                                                                       -------------          -------------            -------------
Total stockholders' equity                                                    96,909                 89,404                 164,975
                                                                       $     399,477          $     295,758             $   460,050
                                                                       =============          =============             ============
</TABLE>

The  accompanying   notes are an integral part of these balance sheets.


<PAGE>
<TABLE>
<CAPTION>

                  DELTA AND PINE LAND COMPANY AND SUBSIDIARIES
                      CONSOLIDATED STATEMENTS OF OPERATIONS
                           FOR THE THREE MONTHS ENDED
                    (in thousands, except per share amounts)
                                   (Unaudited)

                                                                                May 31,              May 31,
                                                                                 1999                 2000
                                                                                 ----                 ----
<S>                                                                              <C>                    <C>
NET SALES AND LICENSING FEES                                             $    158,591       $      177,365
COST OF SALES                                                                 107,213              112,175
                                                                         ------------       --------------
GROSS PROFIT                                                                   51,378               65,190
                                                                         ------------       --------------
OPERATING EXPENSES:
   Research and development                                                     5,325                4,435
   Selling                                                                      4,908                4,022
   General and administrative                                                   3,072                3,700
                                                                         ------------       --------------
                                                                               13,305               12,157
                                                                         ------------       --------------
SPECIALCHARGESANDUNUSUALINCOMEITEM                                               (876)                (820)
                                                                         ------------       --------------
OPERATINGINCOME                                                                37,197               52,213
INTERESTEXPENSE,net                                                            (1,396)                 (77)
OTHER EXPENSE                                                                  (1,752)                (489)
MINORITY INTEREST IN EARNINGS OF SUBSIDIARIES                                    (336)                (141)
                                                                         ------------       --------------
    EFFECT OF ACCOUNTING CHANGE                                                33,713               51,506
INCOME TAX PROVISION                                                           12,965               16,618
                                                                         ------------       --------------
NET INCOME BEFORE CUMULATIVE EFFECT OF
    ACCOUNTING CHANGE                                                          20,748               34,888
CUMULATIVE EFFECT OF CHANGE IN ACCOUNTING FOR
    STARTUP COSTS, NET                                                              -                    -
                                                                         ------------       --------------
NET INCOME                                                                     20,748               34,888
DIVIDENDS ON PREFERRED STOCK                                                      (24)                 (32)
                                                                         ------------       --------------
NET INCOME APPLICABLE TO COMMON SHARES                                   $     20,724      $        34,856
                                                                         ============      ===============
BASIC EARNINGS PER SHARE:
NET INCOME PER SHARE BEFORE CUMULATIVE EFFECT OF
ACCOUNTING CHANGE                                                        $       0.54      $          0.91
CUMULATIVE EFFECT OF ACCOUNTING CHANGE                                              -                    -
                                                                         ------------       --------------
NET INCOME                                                               $       0.54      $          0.91
                                                                         ============      ===============
NUMBER OF SHARES USED IN BASIC EARNINGS
    PER SHARE CALCULATIONS                                                     38,454               38,319
                                                                         ============      ===============
DILUTED EARNINGS PER SHARE:
NET INCOME PER SHARE BEFORE CUMULATIVE EFFECT OF
ACCOUNTING CHANGE                                                        $       0.51      $          0.88
CUMULATIVE EFFECT OF ACCOUNTING CHANGE                                              -                    -
                                                                         ------------      ---------------
NET INCOME                                                               $       0.51      $          0.88
                                                                         ============      ===============
NUMBER OF SHARES IN DIULUTED EARNINGS
    PER SHARE CALCULATIONS                                                     41,018               39,845
                                                                         ============      ===============
DIVIDENDS PER COMMON SHARE                                               $       0.03      $          0.03
                                                                         ============      ===============
</TABLE>

The accompanying notes are an integral part of these statements.


<PAGE>
<TABLE>
<CAPTION>

                  DELTA AND PINE LAND COMPANY AND SUBSIDIARIES
                     CONSOLIDATED STATEMENTS OF OPERATIONS
                           FOR THE NINE MONTHS ENDED
                    (in thousands, except per share amounts)
                                  (Unaudited)

                                                                                May 31,              May 31,
                                                                                 1999                 2000
                                                                                 ----                 ----
<S>                                                                             <C>                    <C>
NET SALES AND LICENSING FEES                                         $        238,587       $      286,116
COST OF SALES                                                                 161,765              189,585
                                                                     ----------------       --------------
GROSS PROFIT                                                                   76,822               96,531
                                                                     ----------------       --------------
OPERATING EXPENSES
Research and development                                                       14,440               13,816
Selling                                                                        12,586               10,855
General and administrative                                                      9,125                9,769
                                                                     ----------------       --------------
                                                                               36,151               34,440
                                                                     ----------------       --------------
SPECIAL CHARGES AND UNUSUAL INCOME ITEM                                        (7,898)              73,407
                                                                     ----------------       --------------
OPERATING INCOME                                                               32,773              135,498
INTEREST EXPENSE, net                                                          (3,020)                (265)
OTHER EXPENSE                                                                  (1,812)                (411)
MINORITY INTEREST IN EARNINGS OF SUBSIDIARIES                                    (311)                  18
                                                                     ----------------       --------------
INCOME BEFORE INCOME TAXES AND CUMULATIVE
   EFFECT OF ACCOUNTING CHANGE                                                 27,630              134,840
INCOME TAX PROVISION                                                           10,914               47,868
                                                                     ----------------       --------------
NET INCOME BEFORE CUMULATIVE EFFECT OF
   ACCOUNTING CHANGE                                                           16,716               86,972
CUMULATIVE EFFECT OF CHANGE IN ACCOUNTING FOR
   STARTUP COSTS, NET                                                               -               (2,965)
                                                                     ----------------       --------------
NET INCOME                                                                     16,716               84,007
DIVIDENDS ON PREFERRED STOCK                                                      (72)                 (96)
                                                                     ----------------       --------------
NET INCOME APPLICABLE TO COMMON SHARES                               $         16,644       $       83,911
                                                                     ================       ==============
BASIC EARNINGS PER SHARE:
NET INCOME PER SHARE BEFORE CUMULATIVE EFFECT OF
   ACCOUNTING CHANGE                                                 $           0.43       $         2.25
CUMULATIVE EFFECT OF ACCOUNTING CHANGE                                              -                (0.08)
                                                                     ----------------       --------------
NET INCOME                                                           $           0.43       $         2.17
                                                                     ================       ==============
NUMBER OF SHARES USES IN BASIC EARNINGS
   PER SHARE CALCULATIONS                                                      38,415               38,541
                                                                     ================       ==============
DILUTED EARNINGS PER SHARE:
NET INCOME PER SHARE BEFORE CUMULATIVE EFFECT OF
    ACCOUNTING CHANGE                                                $           0.41       $         2.16
CUMULATIVE EFFECT OF ACCOUNTING CHANGE                                              -                (0.07)
                                                                     ----------------       --------------
NET INCOME                                                           $           0.41       $         2.09
                                                                     ================       ==============
NUMBER OF SHARES USED IN DILUTED EARNINGS
    PER SHARE CALCULATIONS                                                     41,077               40,157
                                                                     ================       ==============
DIVIDENDS PER COMMON SHARE                                           $           0.09       $         0.09
                                                                     ================       ==============
</TABLE>

The accompanying  notes are an integral part of these statements.


<PAGE>

                  DELTA AND PINE LAND COMPANY AND SUBSIDIARIES
                      CONSOLIDATED STATMENTS OF CASH FLOWS
                            FOR THE NINE MONTHS ENDED
                                 (in thousands)
                                   (Unaudited)
<TABLE>
<CAPTION>

                                                                                May 31,              May 31,
                                                                                 1999                 2000
                                                                                 ----                 ----
<S>                                                                               <C>                   <C>
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income                                                           $         16,716       $       84,007
Adjustments to reconcile net income to net cash provided by
 (used in) operating activities:
  Depreciation and amortization                                                 5,217                4,551
  Loss on sale of equipment                                                     1,835                    -
  Minority interest in net income of subsidiaries                                 311                  (18)
Changes in current assets and liabilities:
  Receivables                                                                (131,391)            (112,450)
  Inventories                                                                 (20,434)                 451
  Prepaid expenses                                                             (2,339)                (193)
  Accounts payable                                                             (6,530)              (4,620)
  Accrued expenses                                                             99,563               69,993
  Deferred income taxes                                                             -                 (204)
  Income taxes payable                                                         16,054               42,985
Change in intangible and other assets                                          (1,585)               1,134
                                                                     ----------------       --------------
        Net cash provided by (used in) operating activities                   (22,583)              85,636
                                                                     ----------------       --------------
CASH FLOWS FROM INVESTING ACTIVITIES:
  Purchases of property and equipment                                          (7,085)              (3,287)
  Proceeds from sale of property and equipment                                    100                    -
                                                                     ----------------       --------------
        Net cash used in investing activities                                  (6,985)              (3,287)
                                                                     ----------------       --------------
CASH FLOWS FROM FINANCING ACTIVITIES:
  Payments of short-term debt                                                 (42,536)              (3,156)
  Payments of long-term debt                                                     (182)             (65,028)
  Dividends paid                                                               (3,532)              (3,562)
  Proceeds from long-term debt                                                  9,000               48,217
  Proceeds from short-term debt                                                56,500                  338
  Minority interest in investment in subsidiaries                               6,103                  250
  Minority interest in dividends paid by subsidiaries                            (263)                (241)
  Payments to acquire treasury stock                                                -               (7,703)
  Proceeds from exercise of stock options and tax benefits
    of stock option exercises                                                   2,295                3,455
                                                                     ----------------       --------------
        Net cash provided by (used in) financing activities                    27,385              (27,430)
                                                                     ----------------       --------------
EFFECTS OF FOREIGN CURRENCY TRANSLATION                                           779                 (626)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS                           (1,404)              54,293
CASH AND CASH EQUIVALENTS, as of August 31                                      8,062                7,552
                                                                     ----------------       --------------
CASH AND CASH EQUIVALENTS, as of May 31                              $          6,658       $       61,845
                                                                     ================       ==============
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
  Cash paid during the nine months for:
        Interest                                                     $          3,100       $        1,100
Income taxes                                                         $            300       $        1,000
</TABLE>

The accompanying notes are an integral part of these statements.


<PAGE>

                  DELTA AND PINE LAND COMPANY AND SUBSIDIARIES
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
        (Amounts in thousands, except percentages and per share amounts)

1.   BASIS OF PRESENTATION

The accompanying  unaudited consolidated financial statements have been prepared
in accordance  with the generally  accepted  accounting  principles  for interim
financial information and Article 10 of Regulation S-X. Accordingly, they do not
include all of the  information  and  footnotes  required by generally  accepted
accounting  principles  for  complete  financial  statements.  In the opinion of
management, all adjustments (consisting of normal recurring accruals) considered
necessary for the fair  presentation of the  consolidated  financial  statements
have been  included.  Due to the seasonal  nature of Delta and Pine Land Company
and subsidiaries'  (the "Company")  business,  the results of operations for the
three and nine  month  periods  ended May 31,  1999 and May 31,  2000 or for any
quarterly period,  are not necessarily  indicative of the results to be expected
for the full  year.  For  further  information  reference  should be made to the
consolidated   financial  statements  and  footnotes  thereto  included  in  the
Company's  Annual Report to  Stockholders on Form 10-K for the fiscal year ended
August 31, 1999.

Certain  prior year balances  have been  reclassified  to conform to the current
year presentation.

2.   ABANDONMENT OF MERGER BY MONSANTO

On May 8, 1998,  the  Company  entered  into a merger  agreement  with  Monsanto
Company  ("Monsanto"),  pursuant to which the  Company  would be merged with and
into  Monsanto.   On  December  20,  1999,   Monsanto  withdrew  its  pre-merger
notification filed pursuant to the Hart-Scott-Rodino  Antitrust Improvements Act
of  1976  ("HSR  Act")  effectively   terminating  Monsanto's  efforts  to  gain
government  approval of the merger. On December 30, 1999, the Company filed suit
(the  "December  30 suit") in the First  Judicial  District  of Bolivar  County,
Mississippi,  seeking,  among  other  things,  the  payment  of the $81  million
termination fee due pursuant to the merger agreement, compensatory damages of $1
billion and punitive  damages in an amount to be proved at trial for  Monsanto's
breach of  contract.  On January 2, 2000,  the Company and  Monsanto  reached an
agreement  whereby the Company would withdraw the December 30 suit, and Monsanto
would  immediately pay the $81 million.  The parties agreed to negotiate in good
faith over the  following  two weeks and Monsanto  agreed to make members of its
senior  management  available to conduct such  negotiations.  It was also agreed
that if no consensual resolution was reached, the lawsuit brought by the Company
would  be  re-filed.  On  January  3,  2000,  Monsanto  paid  to the  Company  a
termination fee of $81 million as required by the merger  agreement.  On January
18,  2000,  the  Company  re-filed  a suit  reinstating  essentially  all of the
allegations contained in the December 30 suit.

The  $81  million  termination  fee,  net of  related  expenses,  is  separately
presented in the income  statement  for the nine months ended May 31, 2000.  The
per diluted share effect is $1.18.

3.   COMPREHENSIVE INCOME

SFAS No.  130,  "Reporting  Comprehensive  Income",  establishes  standards  for
reporting  comprehensive  income and its  components  in  financial  statements.
Comprehensive income, as defined,  includes all non-shareowner changes in equity
and consists of net income, foreign currency translation adjustments, unrealized
gains and losses on available-for-sale securities, and minimum pension liability
adjustments.  Total comprehensive income for the three and nine months ended May
31, 1999 and May 31, 2000 was (in thousands):
<TABLE>
<CAPTION>

                                                               Three Months Ended                    Nine Months Ended
                                                               ------------------                    -----------------
                                                           May 31,             May 31,           May 31,            May 31,
                                                             1999               2000              1999                2000
                                                             ----               ----              ----                ----
<S>                                                           <C>                 <C>               <C>                 <C>
Net income                                           $     20,748        $    34,888       $    16,716         $    84,007
Other comprehensive (loss) income:
  Foreign currency translation (losses) and gains             125                779               779                (626)
     Income tax benefit (expense) related to other
     comprehensive income                                     (48)              (252)             (308)                222
                                                     ------------        -----------       -----------         -----------
Other comprehensive (loss) income, net of tax                  77                527               471                (404)
                                                     ------------        -----------       -----------         -----------
Total comprehensive (loss) income applicable to
common stockholders                                  $    20,825         $    35,415       $    17,187         $    83,603
                                                     ===========         ===========       ===========         ===========
</TABLE>



4.  SEGMENT DISCLOSURES

SFAS  No.  131,  "Disclosures  about  Segments  of  an  Enterprise  and  Related
Information," establishes standards for the way that public business enterprises
report information about operating  segments in annual financial  statements and
requires that those  enterprises  report  selected  information  about operating
segments in interim financial reports issued to shareholders.  The Company is in
a single line of business and operates in two  business  segments,  domestic and
international.   The  Company's  reportable  segments  offer  similar  products;
however,  the  business  units  are  managed  separately  due to the  geographic
dispersion of their  operations.  The Company's chief  operating  decision maker
utilizes  revenue  information  in  assessing  performance  and  making  overall
operating  decisions and resource  allocations.  Profit and loss  information is
reported  by segment to the chief  operating  decision  maker and the  Company's
Board of Directors.

Information about the Company's segments for the three and nine months ended May
31, 1999 and May 31, 2000 is as follows (in thousands):
<TABLE>
<CAPTION>

                                                     Three Months Ended                              Nine Months Ended
                                                     ------------------                             -----------------
                                               May 31,                     May 31,                May 31,                    May 31,
                                                 1999                        2000                   1999                        2000
                                     ----------------           -----------------       ----------------          ------------------
<S>                                               <C>                         <C>                    <C>                         <C>
Net Sales
     Domestic                        $        151,462           $         169,157       $        217,713          $          259,082
     International                              7,129                       8,208                 20,874                      27,034
                                     ----------------           -----------------       ----------------          ------------------
                                     $        158,591           $         177,365       $        238,587          $          286,116
                                     ================           =================       ================          ==================
Operating Income/(Loss)
     Domestic                        $         37,444           $          51,287       $         33,183          $          129,907
     International                               (247)                        924                   (410)                      5,591
                                     ----------------           -----------------       ----------------          ------------------
                                     $         37,197           $          52,213       $         32,773          $          135,498
                                     ================           =================       ================          ==================
</TABLE>

Material Changes in
Assets:

     Accounts receivable increased approximately $112,450 to $260,376 at May 31,
     2000 from $147,926 at August 31, 1999.  This increase is primarily  related
     to technology sublicense revenue due from Monsanto as well as third quarter
     sales in both the domestic and international segments. The royalty payments
     due Monsanto for the Bollgard and Roundup Ready licensing fees is reflected
     in the increase of accrued expenses from August 31, 1999 to May 31, 2000.

5.   NEW ACCOUNTING PRONOUNCEMENTS

SFAS No. 133,  "Accounting for Derivative  Instruments and Hedging  Activities,"
establishes  accounting and reporting standards for the derivative  instruments,
including  certain  derivative  instruments  embedded  in other  contracts,  and
forhedging activities.  The effective date of this statement was delayed via the
issuance of SFAS No. 137. The effective  date for SFAS No. 133 is now for fiscal
years beginning after June 15, 2000,  though earlier  adoption is encouraged and
retroactive  application is prohibited.  Therefore D&PL must adopt the statement
no later than September 1, 2000. Management does not expect the adoption of this
statement to have a material  impact on D&PL's results of operations,  financial
position or cash flows.

SOP 98-5,  "Reporting on the Costs of Startup  Activities,"  requires that costs
related to  start-up  activities  be expensed  as  incurred  and all  previously
capitalized  costs be written  off.  Effective  September  1, 1999,  the Company
adopted the  requirements  of SOP 98-5.  The effect of adopting  this  statement
resulted in a write-off,  net of tax, of approximately $2,965,000 ( or $0.08 per
share).  The adjustment of $2,965,000,  after income tax benefits of $1,817,000,
to retroactively  apply the new method, is recorded in results of operations for
the first fiscal quarter of 2000.

6.   INVENTORIES

Inventories consisted of the following (in thousands):
                                              May 31,     August 31,     May 31,
                                                1999         1999         2000
                                          ----------    ---------   ----------
Finished goods                            $   54,269    $  43,528   $   39,104
Raw materials                                 18,938       15,774       17,786
Growing crops                                  1,028        1,564          766
Supplies and other                               450          969          637
                                          ----------    ---------   ----------
                                              74,685       61,835       58,293
Less reserves                                 (3,754)     (14,108)     (11,017)
                                          ----------    ---------   ----------
                                          $   70,931    $  47,727   $   47,276
                                          ==========    =========   ==========

Substantially  all finished  goods and raw  material  inventory is valued at the
lower of average cost or market. Growing crops are recorded at cost.

7.   PROPERTY, PLANT AND EQUIPMENT

Property, plant and equipment consisted of the following (in thousands):

                                               May 31,    August 31,    May 31,
                                                1999         1999        2000
                                           ---------     --------    ---------
Land and improvements                      $   4,025     $  4,113    $   4,091
Buildings and improvements                    35,249       35,251       37,365
Machinery and equipment                       42,860       43,291       46,589
Germplasm                                      7,500        7,500        7,500
Breeder and foundation seed                    2,000        2,000        2,000
Construction in progress                       4,241        4,789        2,489
                                           ---------     --------    ---------
                                              95,875       96,944      100,034
Less accumulated depreciation                (30,288)     (31,778)     (36,033)
                                           ---------     --------    ---------
                                           $  65,587     $ 65,166    $  64,001
                                           =========     ========    =========

8.   CONTINGENCIES

The Company and Monsanto are named as defendants in five pending  lawsuits filed
in the State of Texas. One which was filed in the 106th Judicial  District Court
of Gaines  County,  Texas on April 27,  2000.  Two  lawsuits  were filed in Lamb
County,  Texas on April 5, 1999; one lawsuit was filed in Lamb County,  Texas on
April 14, 1999; and one lawsuit was filed in Hockley County, Texas, on April 21,
1999.  All of these lawsuits were removed to the United States  District  Court,
Lubbock  Division,  and all but the most recently  filed have been  subsequently
remanded  back to the  state  court  where  they  were  filed.  In each case the
plaintiff alleges,  among other things,  that certain  cottonseed  acquired from
Paymaster  which contained the Roundup Ready gene did not perform as the farmers
had  anticipated and further allege claims that the farmer's crop was injured by
the  application of Round Up. These lawsuits,  however  include  varietal claims
aimed  solely at the  Company.  The first  four  cases  were  identical  to seed
arbitration  claims  previously filed in the state of Texas which were concluded
in the Company's  favor.  The Company and Monsanto have  investigated the claims
and determined that the cause or causes of the alleged  problems are not related
to seed quality or technology but to drought  conditions.  Pursuant to the terms
of the Roundup  Ready  Agreement  between D&PL and  Monsanto,  D&PL tendered the
defense of all these claims to Monsanto and  requested  indemnity.  Monsanto has
agreed to indemnify D&PL in the Gaines  County,  Texas case, but has declined to
indemnify  D&PL in the other cases.  D&PL has no right to  indemnification  from
Monsanto for any claim involving  defective  varietal  characteristics  separate
from or in addition to the failure of the  herbicide  tolerance  gene,  and such
claims are contained in the Lamb County and Hockley County cases.  D&PL believes
these  claims will be  resolved  without any  material  impact on the  Company's
consolidated financial statements.

The Company,  Monsanto and other  parties were named as  defendants in a lawsuit
filed in the Superior Court of Calhoun County,  Georgia on April 19, 1999, which
has been removed to the United States  District Court of the Middle  District of
Georgia,  Albany Division.  An Order was entered in this case on March 30, 2000,
remanding  this case to state  court.  The Company and  Monsanto  are  presently
investigating the claim to determine the cause or causes, if any, of the alleged
problems.  Pursuant to the terms of the Roundup Ready Agreement between D&PL and
Monsanto,  D&PL has tendered the defense of this claim to Monsanto and requested
indemnity,  as Monsanto is  contractually  obligated to defend and indemnify the
Company against all claims arising out of the failure of the Roundup  glyphosate
tolerance  gene.  D&PL will not have a right to  indemnification  from Monsanto,
however, for any claim involving defects in seed separate from or in addition to
the failure of the herbicide  tolerance  gene,  and such claims are contained in
these complaints.  This case was the subject of a seed arbitration case filed in
Georgia  during 1997 which was concluded in the Company's  favor.  D&PL believes
this  lawsuit  will be resolved  without any  material  impact on the  Company's
consolidated financial statements.

On November 15, 1999,  Monsanto and local cotton seed distributors were named in
a lawsuit filed in the Court of Common Pleas, County of Hampton,  State of South
Carolina.  This case was  subsequently  removed  to the United  States  District
Court,  District  of South  Carolina,  Beaufort  Division,  but has  since  been
remanded to the Court of Common Pleas of Hampton County,  South  Carolina.  This
case  requests  class  action  treatment  and alleges that a wide variety of the
Company's  transgenic  cotton  products were defective  because they grew plants
which produced cotton bolls that contained  immature,  defective and rotten seed
in the bolls. The plaintiff in this case seeks class certification of purchasers
of a wide  variety of seed  planted  during the 1999 crop year.  The Company and
Monsanto are presently  investigating the claim;  however, they believe it to be
without  merit  and  their  plan is to  vigorously  defend  this  lawsuit,  with
particular emphasis on defending the class action  allegations.  The Company has
tendered the defense of this claim to Monsanto and requested indemnity. Pursuant
to the Roundup  Ready(R)  Agreement,  Monsanto  is  contractually  obligated  to
indemnify and defend the Company  against all claims  arising out the failure of
the  glyphosate   tolerance   gene.  The  Company  will  not  have  a  right  to
indemnification  from  Monsanto,  however,  for any  claim  involving  defective
varietal  characteristics  separate  from or in  addition  to the failure of the
herbicide tolerance gene, and such claims are contained in these complaints. The
Company  believes  this  claim  is not  one  that is  likely  to  receive  class
treatment.  Accordingly,  D&PL believes that this claim will be resolved without
any material impact on the Company's consolidated financial statements.

On November  15,  1999,  the  Company,  Monsanto  and certain  local  cottonseed
distributors  were  named in an  additional  case  filed in the  Court of Common
Pleas, State of South Carolina.  This case has been removed to the United States
District Court, District of South Carolina, Beaufort Division, and then remanded
back to the Court of Common Pleas.  This case alleges that a wide variety of the
Company's  transgenic  cotton  products were defective  because they grew plants
that produced cotton bolls that contained immature, defective and rotten seed in
the bolls  during the 1999 crop year.  The Company and  Monsanto  are  presently
investigating the claim;  however, they believe it to be without merit and their
plan is to vigorously defend this lawsuit.  The Company has tendered the defense
of this claim to  Monsanto  and  requested  indemnity.  Pursuant  to the Roundup
Ready(R) Agreement,  Monsanto is contractually obligated to indemnify and defend
the  Company  against  all claims  arising  out the  failure  of the  glyphosate
tolerance  gene.  The  Company  will not have a right  to  indemnification  from
Monsanto,  however,  for any claim involving defective varietal  characteristics
separate from or in addition to the failure of the herbicide tolerance gene, and
such claims are  contained in this  complaint.  The Company  believes  that this
claim will be resolved without any material impact on the Company's consolidated
financial statements.

On November  15,  1999,  the  Company,  Monsanto  and certain  local  cottonseed
distributors  were named in a lawsuit  filed in United  States  District  Court,
District of South Carolina,  Beaufort Division.  This case requests class action
treatment  and alleges that a wide variety of the  Company's  transgenic  cotton
products  were  defective  because they grew plants that  produced  cotton bolls
containing  immature,  defective and rotten seed in the bolls.  The plaintiff in
this case seeks class  certification  of  purchasers  of a wide  variety of seed
planted  during the 1999 crop year,  this case seeks to include as class members
only those  individuals  having a claim of $75,000 or  greater.  The Company and
Monsanto are presently  investigating the claim;  however, they believe it to be
without  merit  and  their  plan is to  vigorously  defend  this  lawsuit,  with
particular emphasis on defending the class action  allegations.  The Company has
tendered the defense of this claim to Monsanto and requested indemnity. Pursuant
to the Roundup  Ready(R)  Agreement,  Monsanto  is  contractually  obligated  to
indemnify and defend the Company  against all claims  arising out the failure of
the  glyphosate   tolerance   gene.  The  Company  will  not  have  a  right  to
indemnification  from  Monsanto,  however,  for any  claim  involving  defective
varietal  characteristics  separate  from or in  addition  to the failure of the
herbicide  tolerance gene, and such claims are contained in this complaint.  The
Company  believes  this  claim  is not  one  that is  likely  to  receive  class
treatment.  Accordingly,  D&PL believes that this claim will be resolved without
any material impact on the Company's consolidated financial statements.

On March  30,  1999,  the  Company,  Asgrow  Seed  Company,  L.L.C.,  and  Terra
International were named as defendants in a lawsuit filed in the Fourth Judicial
District  Court,  Parish of Morehouse,  State of  Louisiana,  which has now been
removed  to the  United  States  District  Court  for the  Western  District  of
Louisiana. The suit alleges, among other things, that certain soybean seed which
contained the Roundup Ready gene did not properly  germinate and did not perform
as the farmer had  anticipated  and, in particular,  did not fully protect their
crops from damage following the application of Roundup. The Company and Monsanto
investigated  the claim and determined  that the cause or causes of the farmer's
problems were related to the environment  and  drought-like  conditions,  not to
seed quality or technology. Pursuant to the terms of the Roundup Ready Agreement
between  D&PL and  Monsanto,  D&PL has  tendered  the  defense  of this claim to
Monsanto.  Pursuant to the Roundup Ready  Agreement,  Monsanto is  contractually
obligated to defend and indemnify any and all claims  arising out of the failure
of the  glyphosate  tolerance  gene.  D&PL  believes  this case can be  resolved
without any material impact on the Company's consolidated financial statements.

Sixteen farmers in Mississippi  have filed seed  arbitration  claims against the
Company with the Mississippi  Department of Agriculture  arising from their 1999
crop.  The  Mississippi  Seed  Arbitration  Council has  dismissed  all of these
claims,  however the  farmers  remain free to pursue  legal  action  should they
choose to do so. To date,  none of these farmers have  instituted  legal action.
Pursuant  to the  terms  of the  Bollgard  Gene  Licensing  Agreement,  D&PL has
tendered  the defense of these  claims to  Monsanto,  Monsanto is  contractually
obligated to defend and  indemnify  the Company  against  claims  arising from a
failure of the Bollgard  gene.  Monsanto has declined the  assumption of defense
and  indemnity  of these  cases and,  indeed,  it appears  that the cases do not
involve a  complaint  of the  failure of the gene  technology.  The  Mississippi
Department  of  Agriculture  has not yet  scheduled  a  hearing  on any of these
claims.  The  Company  has moved to dismiss  many of the  claims as having  been
untimely filed.  The Company  believes these claims can be resolved  without any
material impact on the Company's consolidated financial statements.

Approximately  189  cotton  farmers in Georgia  filed  seed  arbitration  claims
against the Company and, in some cases, against Monsanto arising from their 1999
crop.  The Georgia Seed  Arbitration  Council has dismissed all of these claims,
however the farmers  remain free to pursue legal action should they choose to do
so. To date, none of these farmers have instituted legal action. Pursuant to the
terms  of the  Roundup  Ready  Agreement  between  D&PL and  Monsanto,  D&PL has
tendered  the  defense  of these seed  arbitration  claims to  Monsanto  and has
requested  indemnity.  Pursuant  to the  Roundup  Ready  Agreement,  Monsanto is
contractually  obligated to defend and indemnify the Company  against all claims
arising out of the failure of the Roundup glyphosate tolerance gene. The Company
will not have a right  to  indemnification,  however,  for any  claim  involving
defects  in the  seed,  separate  from  or in  addition  to the  failure  of the
herbicide  tolerance  gene,  and such claims were  contained in some of the seed
arbitration claims filed.  Based upon information  received to date, the Company
believes  these  claims  can be  resolved  without  any  material  impact on the
Company's consolidated financial statements.

In  1998,  one  Arkansas  farmer  filed  a  complaint  with  the  Arkansas  Seed
Arbitration  Council related to an alleged crop performance issues in 1997. This
claim was recently  dismissed by the Arkansas Seed  Arbitration  Council however
the farmer  remains free to pursue  legal  action  should he choose to do so. To
date, the farmer has not instituted legal action. This case alleges that certain
Roundup  Ready  cottonseed  marketed by the Company in 1997 failed to perform as
the farmer had anticipated  and caused the farmer to suffer crop loss.  Pursuant
to the Roundup Ready Agreement between D&PL and Monsanto,  D&PL has tendered the
defense of this claim to  Monsanto.  Pursuant  to the Roundup  Ready  Agreement,
Monsanto is  contractually  obligated to defend and indemnify any and all claims
arising out of the failure of the glyphosate gene tolerance.  D&PL believes this
case can be resolved  without any material impact on the Company's  consolidated
financial statements.

Twelve farmers in the State of Alabama filed seed arbitration claims against the
Company for their 1999 crop year. The Company is in the process of investigating
these claims to determine the cause or causes,  if any, of the alleged problems.
One of the claims was heard on May 3, 2000,  and dismissed on June 7, 2000,  for
lack of merit.  The remaining claims were dismissed  without  hearing.  With the
exception of one seed arbitration  claim, all the other farmers are now pursuing
formal  litigation  against  D&PL and  Monsanto.  Pursuant  to the  terms of the
Roundup Ready Agreement between D&PL and Monsanto, D&PL has tendered the defense
of these  seed  arbitration  claims to  Monsanto  and has  requested  indemnity.
Pursuant to the Roundup Ready Agreement,  Monsanto is contractually obligated to
defend and indemnify the Company  against all claims  arising out of the failure
of the Roundup Ready gene. The Company will not have a right to indemnification,
however,  for any  claim  involving  defects  in the seed,  separate  from or in
addition to the failure of the  herbicide  tolerance  gene,  and such claims are
contained in some of the seed arbitration  claims filed. The Alabama  Department
of Agriculture has not yet scheduled hearing dates on any of these claims. Based
upon  information  received to date,  the Company  believes  these claims can be
resolved  without any material  impact on the Company's  consolidated  financial
statements.

Six farmers in the State of Florida have filed  arbitration  claims  against the
Company  for the 1999  crop  year,  however,  three of those  claims  have  been
withdrawn  by the  farmers  due to higher  than  expected  yields.  The  Florida
Department of Agriculture has not yet scheduled hearings on any of these claims.
The Company believes these claims can be resolved without any material impact on
the Company's consolidated financial statements.

In 1999,  112  farmers in the State of South  Carolina  filed  seed  arbitration
claims  against the  Company.  The Company  and  Monsanto  are in the process of
investigating  these  claims to  determine  the cause or causes,  if any, of the
alleged problem. Pursuant to the terms of the Roundup Ready(R) Agreement between
the Company and  Monsanto,  the Company has  tendered  the defense of these seed
arbitration claims to Monsanto and requested indemnity.  Pursuant to the Roundup
Ready(R) Agreement,  Monsanto is contractually obligated to defend and indemnify
the Company  against all claims  arising out of the failure of the Roundup Ready
gene.  D&PL  will  have no right to  indemnification,  however,  for any  claims
involving  defective  seed,  separate  from or in addition to the failure of the
herbicide  tolerance gene, and such claims are contained in the seed arbitration
claims filed in South Carolina. The South Carolina Department of Agriculture has
not yet  scheduled a hearing on any of these  claims.  The Company  believes the
claims to be without merit and that the farmers  complaints are  environmentally
induced and not related to seed performance;  accordingly,  the Company believes
these  claims can be  resolved  without  any  material  impact on the  Company's
consolidated financial statements.  In the event classes are certified in either
of  the  two  pending   litigation  matters  in  South  Carolina  seeking  class
certification,   it  is  likely  these  claims  will  become  subsumed  in  that
litigation.

The Company,  Monsanto and seed  distributors  including Dixie Ag Supply,  Inc.,
Central  Alabama  Farmers Co-Op and Helena  Chemical  Company,  and employees of
those  entities,  were named as defendants in 10 lawsuits  filed in the State of
Alabama.  Two lawsuits were filed in Lowndes County,  Alabama,  one on March 14,
2000, and one on March 22, 2000; one lawsuit was filed in Dallas County, Alabama
on March 22, 2000,  three cases were filed in Autauga  County,  Alabama,  one on
March 27, 2000,  two on March 23,  2000,  three  lawsuits  were filed in Chilton
County,  Alabama,  three on March 22, 2000,  and one lawsuit was filed in Elmore
County,  Alabama on March 22, 2000.  These  lawsuits  were removed to the United
States District  Court.  All have  subsequently  been remanded back to the state
court in which they were filed. In each case the plaintiff alleges,  among other
things, that certain cottonseed varieties purchased from D&PL did not perform as
the farmer had  anticipated.  These lawsuits also include  varietal claims aimed
solely  at  the  Company.  The  Company,  Monsanto  and  other  defendants  have
investigated  the claims to determine the cause or causes of the allege problems
and believe that all the plaintiff's claims were enviromentally  induced and not
related to the  performance  of the  Company's  seed or  Monsanto's  technology.
Pursuant  to the  terms  of the  Roundup  Ready(R)  agreement  between  D&PL and
Monsanto,  D&PL has  tendered  the  defense  of these  claims  to  Monsanto  and
requested  indemnity.  Pursuant to the Roundup  Ready(R)  agreement  Monsanto is
contractually  obligated to defend and indemnify the Company  against all claims
arising out of the failure of the Roundup Ready gene. D&PL will have no right to
indemnification  from  Monsanto  however,  for  any  claim  involving  defective
varietal  characteristics  separate  from or in  addition  to the failure of the
herbicide tolerance gene, and such claims are contained within these complaints.
To date Monsanto has declined D&PL's request for indemnity and defense.  Certain
of these claims were earlier  filed as seed  arbitration  claims in the state of
Alabama which were dismissed and, based on  investigation to date, D&PL believes
these  claims will be  resolved  without any  material  impact on the  Company's
consolidated financial statements.

One other  farmer  has  filed  suit in the  Circuit  Court of  Escambia  County,
Alabama,  this suit was filed on April 5, 2000.  This suit  alleges a failure of
glyphosate gene tolerance or  alternatively  alleges the mislabeling of the seed
involved  in the  complaint.  This claim was the  subject of a seed  arbitration
hearing  that  resulted  in a  favorable  ruling for the  Company.  The  Company
believes  this  claim  will be  resolved  without  any  material  impact  on the
Company's consolidated financial statements.

In  May  1998,  five  individual  alleged  shareholders  brought  suits  against
Monsanto,  the Company and its Board of Directors  ("Directors") in the Court of
Chancery in New Castle County,  Delaware (the "Delaware  Chancery  Court").  The
complaints  alleged that the  consideration to be paid in the proposed merger of
the Company  with  Monsanto  was  inadequate  and that the  Company's  Directors
breached  their  fiduciary  duties to the  Company's  stockholders  by voting to
approve the  Agreement and Plan of Merger,  and that Monsanto  aided and abetted
the alleged breach of fiduciary duty. The complaints were  consolidated into one
action,  which sought a declaration  that the action was maintainable as a class
action,  that the merger be enjoined,  or  alternatively,  rescinded,  and/or an
award of  unspecified  compensatory  damages if the merger  was  consummated.  A
settlement  agreement was reached with the named  plaintiffs  in November  1998.
This  settlement  was  contingent  on  consummation  of the merger.  In light of
Monsanto's  termination of the merger, the Company believes that this lawsuit is
in effect, moot.

In  December  1999  and  January  2000,  two  individual  alleged   shareholders
(including  some of the  plaintiffs  in the suits filed in May 1998) brought two
new suits (now consolidated) against the Directors, the Company, and Monsanto in
the  Delaware  Chancery  Court.  These  complaints  allege  that  the  Company's
Directors  breached  fiduciary  duties  by  failing  to seek  compensation  from
Monsanto  for  breach of the  Agreement  and Plan of Merger  and by  failing  to
explore strategic  alternatives  after the termination of the merger transaction
by Monsanto and that  Monsanto  aided,  abetted,  and  assisted  the  Directors'
alleged  breaches of fiduciary  duty.  The  plaintiffs  sought to maintain these
actions as class actions and demanded  injunctive relief requiring the Directors
to  maximize  shareholder  value and,  alternatively,  unspecified  compensatory
damages,  attorneys' fees, and costs.  Monsanto has filed a cross-claim  against
D&PL in those consolidated  cases seeking a declaratory  judgment that it is not
liable to the  Company  for breach of contract  for  failure to  consummate  the
merger.  Monsanto seeks no monetary  recovery  against the Company.  The Company
believes that plaintiffs'  complaints,  which were filed before  plaintiffs were
aware  of the  actions  undertaken  by the  Company  and its  Directors  to seek
compensation from Monsanto and to maximize shareholder value in the aftermath of
Monsanto's  termination of the merger transaction,  are without merit and should
be  dismissed.  On June 21, 2000,  the Court ruled for the Company and dismissed
the December 1999 and January 2000  shareholder  suits. The Company has moved to
dismiss  Monsanto's  cross-claim or,  alternatively,  to stay the cross-claim in
favor  of  the  Company's  suit  against   Monsanto  filed  in  state  court  in
Mississippi. That motion is pending.

In  October  1996,   Mycogen  Plant  Science,   Inc.  and   Agrigenetics,   Inc.
(collectively  "Mycogen")  filed a lawsuit in U.S.  District  Court in  Delaware
naming D&PL,  Monsanto and DeKalb  Genetics as  defendants  alleging that two of
Mycogen's  recently  issued  patents have been  infringed by the  defendants  by
making,  selling,  and licensing seed that contains the Bollgard gene. The suit,
which  went to  trial  in  January  1998,  sought  injunctions  against  alleged
infringement, compensatory damages, treble damages and attorney's fees and court
costs.  A jury found in favor of D&PL and  Monsanto  on issues of  infringement.
Mycogen  subsequently  re-filed a motion  for a new trial and for a judgment  in
favor of Mycogen as a matter of law. The trial court has ruled in these  motions
holding for Mycogen on certain  issues but  sustaining the jury verdict in favor
of D&PL and Monsanto.  Mycogen has appealed to the U.S. Court of Appeals for the
Federal Circuit.  Pursuant to the terms of the Bollgard  Agreement,  Monsanto is
required to defend D&PL against  patent  infringement  claims and indemnify D&PL
against damages from any patent infringement claims and certain other losses and
costs. Due to Monsanto's obligation to indemnify D&PL, the Company believes that
the  resolution of this matter will not have a material  impact on the Company's
consolidated financial statements.

In December 1999,  Mycogen Plant Science,  Inc., an Australian  affiliate of Dow
Chemical Co.  ("Mycogen-Australia") filed suit in the Federal Court of Australia
against  Monsanto  Australia  Limited and  Deltapine  Australia Pty Limited (the
Australian affiliates of Monsanto and D&PL, respectively) alleging that sales in
Australia of  genetically-modified  cotton seed  containing  Monsanto's  Bt gene
infringe two  Australian  patents held by  Mycogen-Australia.  The suit seeks to
enjoin sales of allegedly  infringing  seed in Australia  and monetary  damages.
This suit  involves  issues  similar  to those in the above  described  Delaware
litigation  but will be decided under  Australian  patent law which,  unlike the
United States, applies a "first to file" priority rule. Monsanto and D&PL, which
are  cooperating  in defense  of this suit,  are  relying on other  defenses  to
infringement  claims. At the present time, the outcome of this litigation cannot
be predicted.

A corporation  owned by the son of the Company's former  Guatemalan  distributor
sued in 1989  asserting  that  the  Company  violated  an  agreement  with it by
granting  to another  entity an  exclusive  license in certain  areas of Central
America and southern  Mexico.  The suit seeks  damages of  5,300,000  Guatemalan
quetzales  (approximately  $700,000 at current exchange rates) and an injunction
preventing the Company from distributing seed through any other licensee in that
region.  The  Guatemalan  court,  where  this  action is  proceeding,  has twice
declined  to  approve  the  injunction  sought.  Management  believes  that  the
resolution  of the  matter  will not have a  material  impact  on the  Company's
consolidated financial statements.  The Company continues to offer seed for sale
in Guatemala.

In November 1999 a distributor of Sure-Grow  brand cotton seed in Greece brought
suit in U. S. District  Court in Delaware  seeking to enjoin the  termination of
its distributorship  (which become effective on November 30, 1999) a declaratory
judgment  that  the  Company's   termination  of  its  distributorship  was  not
effective,  compensatory  damages  of not less than $6 million  and  unspecified
punitive damages.  The distributor has also filed a request for arbitration with
the American  Arbitration  Association and a suit seeking injunctive relief in a
court in  Thessaloniki,  Greece.  In January  2000 the U. S.  District  Court in
Delaware  denied the request for  injunctive  relief.  The Company has sought an
injunction  against the  distributor's  proceeding with litigation in the Greece
Court.  The Company  believes that the former  distributor's  claims are without
merit and that these claims will be resolved  without any material impact on the
Company's  consolidated  financial  statements.  The Company  continues to offer
cotton seed (including  seed of the Sure-Grow  brand) for sale in Greece through
another distributor.

On July 18, 1996, the United States  Department of Justice,  Antitrust  Division
("USDOJ"),  served a Civil Investigative Demand (the "1996 CID") on D&PL seeking
information  and  documents  in  connection  with  its   investigation   of  the
acquisition  by D&PL of the stock of Arizona  Processing,  Inc.,  Ellis Brothers
Seed, Inc. and Mississippi Seed, Inc. (which own the outstanding common stock of
Sure Grow  Seed,  Inc).  The 1996 CID  stated  that the USDOJ was  investigating
whether these  transactions may have violated the provisions of Section 7 of the
Clayton Act, 15 USC 18. D&PL responded to the 1996 CID,  employees were examined
in 1997 by the USDOJ,  and D&PL is committed to full cooperation with the USDOJ.
At the  present  time,  the  ultimate  outcome  of the  investigation  cannot be
predicted.

On August 9, 1999, D&PL and Monsanto received Civil  Investigative  Demands from
the USDOJ (the "1999  CIDs"),  seeking to determine  whether there have been any
inappropriate exchanges of information between Monsanto and D&PL or if any prior
acquisitions are likely to have substantially  lessened  competition in the sale
or development  of cottonseed or cottonseed  genetic  traits.  D&PL has complied
with the USDOJ's request for  information and documents.  The USDOJ has taken no
further action on the 1999 CIDs since D&PL and Monsanto's responses were filed.

In May 2000,  three cotton farmers and a seed dealer brought a class action suit
in the United States District Court for the Northern District of Alabama against
the Company, Monsanto and D&M International,  LLC ("D&M"). The Complaint alleges
that the defendants have attempted to monopolize and/or restrain trade in the U.
S.  markets for cotton seed and  herbicides  in violation of the Sherman Act and
the Clayton  Act and seeks  damages and other  relief for the  plaintiffs  and a
purported  class of similarly  situated  parties.  The Company has  responded to
allegations  relating  the  Company  and D&M and has  demanded  that the suit be
dismissed.  Company  believes that the claims in this lawsuit  pertaining to the
Company and D&M are  without  merit and will be  resolved  without any  material
impact on the Company's consolidated financial statements.

9.  EARNINGS PER SHARE

Basic earnings per share before the cumulative  effect of a change in accounting
principle  was  calculated  using the weighted  average  number of common shares
outstanding  for each  reporting  period (38,454 and 38,319 for the three months
ended May 31,  1999 and 2000,  respectively,  and 38,415 and 38,541 for the nine
months ended May 31, 1999 and 2000,  respectively).  Diluted  earnings per share
before the  cumulative  effect of a change in accounting  principle was computed
taking into  account  the effect of dilutive  common  share  equivalents  (which
totaled  2,564  and  1,526 for the  three  months  ended May 31,  1999 and 2000,
respectively,  and 2,662 and 1,616 for the nine  months  ended May 31,  1999 and
2000, respectively).

Dilutive  common  share  equivalents  consist  of both  the  Company's  Series M
Convertible  Non-Voting Preferred Shares and outstanding stock options under the
Company's  1993  Stock  Option  Plan  and the  1995  Long-Term  Incentive  Plan.
Approximately 169,000 and 1,532,000, outstanding stock options were not included
in the computation of diluted  earnings per share for the three months ended May
31,  1999 and  2000,  respectively,  and  approximately  169,000  and  1,484,000
outstanding  stock  options  were not  included  in the  computation  of diluted
earnings   per  share  for  the  nine  months  ended  May  31,  1999  and  2000,
respectively, because the effect of their exercise was not dilutive based on the
average market price of the Company's common stock for each respective reporting
period. These options expire at various dates from 2006 to 2009.

PART I.

Item 2. Management's  Discussion and Analysis of Financial Condition and Results
     of Operations

Overview

On May 8,  1998,  Delta and Pine  Land  Company  and  subsidiaries,  a  Delaware
Corporation  ("D&PL" or the  "Company")  entered  into a merger  agreement  with
Monsanto  Company  ("Monsanto"),  pursuant to which Delta and Pine Land  Company
would be merged with and into Monsanto.  On December 20, 1999, Monsanto withdrew
its filing under the HSR Act thereby effectively  abandoning plans to consummate
the merger. On January 3, 2000, Monsanto paid Delta and Pine Land Company an $81
million termination fee, which, net of related expenses, is separately presented
in the  accompanying  income  statement.  The diluted  per share  effect of this
non-recurring  payment (net of tax and related  expenses) was $1.18 for the nine
months ended May 31, 2000.

RESULTS OF OPERATIONS

The following sets forth selected operating data of the Company (in thousands):
<TABLE>
<CAPTION>

                                          For the Three Months Ended            For the Nine Months Ended
                                           May 31,            May 31,            May 31,             May 31,
                                            1999               2000               1999                 2000
                                       ---------          ---------          ---------            ---------
<S>                                         <C>                 <C>             <C>                     <C>
Operating results -
Net sales and licensing fees           $ 158,591          $ 177,365          $ 238,587            $ 286,116
Gross profit                              51,378             65,190             76,822               96,531
Operating expenses:
 Research and development                  5,325              4,435             14,440               13,816
 Selling                                   4,908              4,022             12,586               10,855
 General and administrative                3,072              3,700              9,125                9,769
 Special charges and unusual income item    (876)              (820)            (7,898)              73,407
Operating income                          37,197             52,213             32,773              135,498
Income before income taxes and
 cumulative effect of accounting change   33,713             51,506             27,630              134,840
Net income applicable to common shares  $ 20,724          $  34,856          $  16,644            $  83,911
</TABLE>


The following  sets forth  selected  balance sheet data of the Company as of the
following periods (in thousands):
<TABLE>
<CAPTION>

                                               May 31,                August 31,                   May 31,
                                                1999                     1999                       2000
                                                ----                     ----                       ----
<S>                                             <C>                     <C>                          <C>
Balance sheet summary-
Current assets                          $    322,025              $   217,543                $   384,233
Current liabilities                          233,447                  175,243                    280,492
Working capital                               88,578                   42,300                    103,741
Property, plant and equipment, net            65,587                   65,166                     64,001
Total assets                                 399,477                  295,758                    460,050
Outstanding borrowings                        70,058                   20,819                      1,190
Stockholders' equity                          96,909                   89,404                    164,975
</TABLE>


Three months ended May 31, 2000, compared to three months ended May 31, 1999:

Net sales and licensing  fees in the third quarter ended May 31, 2000  increased
12% to $177.4  million  from  $158.6  million in the same  quarter in 1999.  The
increase in sales is the result of i) an increase in planted cotton acreage, ii)
a shift by farmers from both  conventional  varieties and single gene  varieties
containing either the Bollgard or Roundup Ready gene technology to higher priced
transgenic products that contain both gene technologies, and iii) an increase in
international  sales.  Operating expenses declined to $12.2 million in 2000 from
$13.3   million  in  the  same  quarter  in  1999  due  primarily  to  the  1999
reorganization of the sales and marketing and technical service staffs. Interest
expense  decreased  to  $77,000  from  $1.4  million  due to  lower  outstanding
borrowings  due, in part, to the collection of the $81 million  termination  fee
from Monsanto. During the third quarter, the Company revised its estimate of the
effective  income tax rate for the year  ending  August 31,  2000 to 35.5%.  The
effect of this change in estimate  was recorded in the third  quarter  ended May
31, 2000.

Nine months ended May 31, 2000, compared to nine months ended May 31, 1999:

Net sales and  licensing  fees  increased to $286.1  million for the nine months
ended May 31, 2000 from $238.6  million in 1999.  This increase is the result of
sales of  cottonseed  varieties  containing  both the Bollgard and Roundup Ready
genes nearly doubling in 2000 over 1999 and an increase in  international  sales
to $27.0 million from $20.9 million,  the effects of which were partially offset
by a $7.2 million decline in soybean sales.  Transgenic cottonseed unit sales in
2000  approximated  85% of unit sales in 2000  compared to 80% in 1999.  Roundup
Ready  soybean  unit  sales  increased  to 69% of units sold in 2000 from 60% in
1999.

Operating  expenses  for the nine months  ended May 31,  2000  declined to $34.4
million from $36.2 in 1999.  The decrease is  primarily  attributed  to the 1999
reorganization  of sales and  marketing and technical  service  staffs,  and the
closing of the Stuttgart,  Arkansas breeding station in contemplation of opening
two new breeding stations which are not yet operating at full scale.

Interest  expense  declined to $265,000 in 2000 compared to $3.0 million in 1999
due to lower average borrowing as a result of cash generated from operations and
the receipt of the $81 million termination fee from Monsanto.

LIQUIDITY AND CAPITAL RESOURCES

The seasonal nature of the Company's  business  significantly  impacts cash flow
and working capital requirements.  The Company maintains credit facilities, uses
early  payments  by  customers  and uses cash from  operations  to fund  working
capital needs. For more than 18 years D&PL has borrowed on a short-term basis to
meet seasonal working capital needs.

In the United States, D&PL purchases seed from contract growers in its first and
second fiscal quarters. Seed conditioning,  treating and packaging commence late
in the first  fiscal  quarter and  continue  through the third  fiscal  quarter.
Seasonal  borrowings  normally  commence in the first fiscal quarter and peak in
the third fiscal quarter.  Loan  repayments  normally begin in the middle of the
third fiscal quarter and are typically  completed by the first fiscal quarter of
the following  year.  D&PL also offers  customers  financial  incentives to make
early payments. To the extent D&PL attracts early payments from customers,  bank
borrowings under the credit facility are reduced.

The Company  records  receivables  for domestic  licensing  fees on Bollgard and
Roundup Ready seed sales as the seed is shipped, usually in the Company's second
and third  quarters.  The Company  has  contracted  the  billing and  collection
activities  for  Bollgard  and Roundup  Ready  licensing  fees to  Monsanto.  In
September,  the technology fees are due at which time D&PL receives payment from
Monsanto. D&PL then pays Monsanto its royalty for the Bollgard and Roundup Ready
licensing fees.

In April 1998, the Company  entered into a syndicated  credit  facility with its
existing  lender  and  two  other  financial  institutions  which  provides  for
aggregate borrowings of $110 million.  This agreement provides a base commitment
of $55 million and a seasonal commitment of $55 million.  The base commitment is
a long-term loan that may be borrowed upon at any time and is due April 1, 2001.
The seasonal  commitment  is a working  capital loan that may be drawn upon from
September 1 through June 30 of each fiscal year and expires April 1, 2001.  Each
commitment  offers  variable  and fixed  interest  rate options and requires the
Company to pay facility or commitment fees and to comply with certain  financial
covenants.  At May 31,  2000,  the  Company  had  $55.0  million  available  for
borrowing  under the base  commitment  and  $55.0  million  available  under its
seasonal  commitment.  In addition the lead lender has approved a $25.0  million
credit line that can be  activated  by the Company as needed.  Such  facility is
generally available for up to 180 days and bears interest at rates comparable to
the existing facility.

The financial  covenants under the loan  agreements  require the Company to: (a)
maintain a ratio of total  liabilities  to  tangible  net worth at August 31, of
less than or equal to 2.25 to 1 (4.0 to 1.0 at the Company's other quarter ends)
(b) maintain a fixed  charge  ratio at the end of each  quarter  greater than or
equal to 2.0 to 1.0 and (c) maintain at all times tangible net worth of not less
than the sum of (i) $40  million  plus (ii) 50% of net income  (but not  losses)
determined on the last day of each fiscal year, commencing with August 31, 1998.
At May 31, 2000, the Company was in compliance with these covenants.

Capital  expenditures  for the first nine months of 2000 were $3.3 million which
was a decrease  from $7.1 million in the first nine months of 1999.  The Company
anticipates that domestic capital  expenditures will approximate $8.0 million in
2000,  excluding expected capital  expenditures for foreign joint ventures which
will be funded by cash from  operations,  borrowings or  investments  from joint
venture partners,  as necessary.  Capital expenditures in 2000 for international
ventures are  expected to range from $1.0  million to $2.0 million  depending on
the timing and outcome of such projects.

Cash provided from  operations,  early  payments from  customers and  borrowings
under the loan agreement should be sufficient to meet the Company's 2000 working
capital needs.

In the third  quarter of 2000,  the Board of  Directors  authorized  a quarterly
dividend of $0.03 per share, paid June 12, 2000 to the stockholders of record on
May 31, 2000. It is anticipated that quarterly dividends of $0.03 per share will
continue  to be paid,  although  the  Board of  Directors  reviews  this  policy
quarterly.

In  January  2000,  the Board of  Directors  approved  a stock  repurchase  plan
pursuant to which the  Company  expects to  purchase  up to  $50,000,000  of its
outstanding  common  stock.  The  shares  repurchased  will  be used  for  stock
issuances  pursuant to the Company's  stock option plans and for other corporate
purposes.  During the third quarter ended May 31, 2000, D&PL repurchased 101,200
shares at an average price of $17.55 per share.


<PAGE>

PART II.   OTHER INFORMATION

Item 1.  Legal Proceedings

See Part I, Item 1, Footnote 8

Item 4.  Submission of Matters to a Vote of Security Holders

The Annual Meeting of the  Shareholders  of Delta and Pine Land Company was held
March 30, 2000 and the  following  matters were brought to a vote with the noted
results:
<TABLE>
<CAPTION>

        Item Number                         For                  Against                   Abstain                Non-Voted
        -----------                         ---                  -------                   -------                ---------
<S>                                         <C>                      <C>                      <C>                  <C>
1.   Directors:
     Roger D. Malkin                 32,189,407                     306                     68,907                        0

     Jon E. M. Jacoby                32,190,678                     306                     67,636                        0

                                            For                  Against                   Abstain                Non-Voted
                                            ---                  -------                   -------                ---------
2.   Amend the Company's 1995
     Long Term Incentive Plan to
     increase the number of shares
     available for grant from
     2,560,000 to 5,120,000          18,500,749               3,544,264                    304,075                9,909,532

                                            For                 Against                    Abstain                Non-Voted
                                            ---                 -------                    -------                ---------
3.   Approve Arthur Andersen,
     LLP as principal independent
     certified public accountants
     for the fiscal year ending
     August 31, 2000                 32,216,945                  30,100                     11,575                        0
</TABLE>

Item 5. Business

Domestic

Delta and Pine Land Company, a Delaware corporation, and subsidiaries ("D&PL" or
the "Company") is primarily  engaged in the breeding,  production,  conditioning
and  marketing of  proprietary  varieties of cotton  planting seed in the United
States  and  other  cotton  producing  nations.  D&PL  also  breeds,   produces,
conditions and distributes soybean planting seed in the United States.

Since 1915, D&PL has bred,  produced and/or marketed upland picker  varieties of
cotton planting seed for cotton varieties that are grown primarily east of Texas
and in Arizona.  The Company has used its  extensive  classical  plant  breeding
programs to develop a gene pool  necessary for producing  cotton  varieties with
improved  agronomic  traits  important  to farmers,  such as crop yield,  and to
textile manufacturers, such as enhanced fiber characteristics.

In 1980,  D&PL added soybean seed to its product line. In 1996,  D&PL  commenced
commercial  sales in the  United  States  of  cotton  planting  seed  containing
Bollgard(R)  gene  technology  licensed from Monsanto which  expresses a protein
toxic to certain lepidopteran cotton pests. Since 1997, D&PL has marketed in the
U.S.  cotton  planting  seed that  contains a gene that  provides  tolerance  to
glyphosate-based herbicides ("Roundup Ready(R) Cotton"). In 1997, D&PL commenced
commercial  sales in the U.S. of soybean planting seed that contains a gene that
provides tolerance to glyphosate-based herbicides ("Roundup Ready Soybeans"). In
1998,  D&PL  commenced  sales of  cottonseed  of varieties  containing  both the
Bollgard and Roundup Ready genes.

International

During the 1980's, as a component of its long-term growth strategy,  the Company
began to market its  products,  primarily  cottonseed,  internationally.  Over a
period of years,  the Company has  strengthened  and expanded its  international
staff  in order to  support  its  expanding  international  business,  primarily
through joint ventures.  In foreign  countries,  cotton acreage is often planted
with  farmer-saved  seed which has not been  delinted  or treated  and is of low
overall quality.  Management believes that D&PL has an attractive opportunity to
penetrate  foreign  markets  because of its widely  adaptable,  superior  cotton
varieties,  technological  know-how in producing and  conditioning  high-quality
seed and brand name  recognition.  Furthermore,  in many  countries the Bollgard
gene  technology  and Roundup  Ready gene  technology  licensed from Monsanto is
effective and could bring value to farmers.

D&PL sells its products in foreign  countries  through (i) export sales from the
U.S.,  (ii)  direct   in-country   operations  and  to  a  lesser  degree  (iii)
distributors  or licensees.  The method varies and evolves,  depending  upon the
Company's  assessment of the  potential  size and  profitability  of the market,
governmental policies,  currency and credit risks,  sophistication of the target
country's  agricultural  economy, and costs (as compared to risks) of commencing
physical  operations in a particular  country.  Prior to 1999, a majority of the
Company's  international  sales  resulted  from  exports  from the  U.S.  of the
Company's  products rather than direct  in-country  operations.  In 1999, direct
in-country  operations  through  joint  ventures  or  subsidiaries   (primarily,
Argentina,  Australia,  Brazil, China, and South Africa) comprised over one-half
of total international sales which represented approximately 10% of consolidated
sales.

Joint Ventures

D&M  International,  LLC, is a venture through which D&PL (the managing  member)
and  Monsanto  plan  to  introduce,  in  combination,  cotton  planting  seed in
international  markets  combining  D&PL's acid  delinting  technology  and elite
germplasm  and  Monsanto's  Bollgard  and Roundup  Ready gene  technologies.  In
November 1995, D&M International,  LLC formed a subsidiary,  D&PL China Pte Ltd.
("D&PL  China").  In November  1996,  D&PL China  formed  with  parties in Hebei
Province,  one of the major cotton producing regions in the People's Republic of
China,  Hebei Ji Dai  Cottonseed  Technology  Company Ltd.  ("Ji Dai"),  a joint
venture controlled by D&PL China. In June 1997, Ji Dai commenced construction of
a cottonseed conditioning and storage facility in Shijiazhuang,  Hebei Province,
China,  under  terms  of the  joint  venture  agreement.  The new  facility  was
completed in December 1997 and seed processing and sales commenced in 1998.

In December 1997,  D&M  International,  LLC,  formed a joint venture with Ciagro
S.R.L.  ("Ciagro"), a distributor of agricultural inputs in the Argentine cotton
region,  for the  production and sale of genetically  improved  cottonseed.  CDM
Mandiyu S.R.L., is owned 60% by D&M  International,  LLC, and 40% by Ciagro. The
cotton  region,  primarily  comprised of the  Provinces  of Chaco,  Santiago del
Estero,  Salta and Jujuy,  presently has 1.2 million  acres of cotton  requiring
9,000  tons of  cotton  planting  seed per year.  CDM  Mandiyu  S.R.L.  has been
licensed to sell D&PL  cotton  varieties  containing  Monsanto's  Bollgard  gene
technology.  Sales of such varieties commenced in 1999. Future plans include the
production and sale of Roundup Ready  cottonseed  varieties  pending  government
approval.

In July 1998,  D&PL China and the Anhui  Provincial  Seed  Corporation  formed a
joint  venture,  Anhui An Dai Cotton Seed  Technology  Company,  Ltd. ("An Dai")
which is located in Hefei City,  Anhui Province,  China.  Under the terms of the
joint venture  agreement,  the newly formed  entity will produce,  condition and
sell acid  delinted  D&PL  varieties  of  cottonseed  which  contain  Monsanto's
Bollgard gene. In the fall of 1998, An Dai harvested  sufficient  seed from seed
plots in Anhui to plant up to 250,000  acres.  The joint venture did not receive
authority  to operate from the Chinese  government  until after the 1999 selling
season was completed.  Therefore,  commercial  sales are expected to commence in
early 2000.

In November 1998, D&M International LLC and Maeda  Administracao e Participacoes
Ltda, an affiliate of Agropem - Agro Pecuria Maeda S.A.,  formed a joint venture
in Minas Gerais,  Brazil. The new company,  MDM Maeda Deltapine Monsanto Algodao
Ltda., will produce,  condition and sell  acid-delinted D&PL varieties of cotton
planting  seed.  The new company  produced and  delinted  enough  cottonseed  of
conventional  varieties in 1999 to plant up to 900,000  acres.  The newly formed
company  will  introduce  transgenic  cottonseed  varieties,  both  Bollgard and
Roundup  Ready,  to the  Brazilian  market  as  soon  government  approvals  are
obtained.

Subsidiaries

The  Company's  delinting  plants in  Groblersdal,  South Africa and  Catamarca,
Argentina process foundation seed grown in these countries.  The use of Southern
Hemisphere  winter  nurseries  and seed  production  programs  such as these can
accelerate the introduction of new varieties because D&PL can raise at least two
crops per year by taking  advantage of the Southern  Hemisphere  growing season.
The  Company  maintains  a  winter  nursery  in  Costa  Rica  and  is  currently
constructing a delinting  plant there to process  foundation  seed for export to
the United States.  Multiple  winter  nursery  locations are used to manage seed
production risks.

Deltapine  Australia  Pty. Ltd., a wholly owned  Australian  subsidiary of D&PL,
conducts  breeding,  production,  conditioning  and marketing of cotton planting
seed in Australia.  Certain varieties developed in Australia are well adapted to
other Southern  Hemisphere cotton producing  countries and Australian  developed
varieties  are  exported  to  these  areas.  The  Company  sells  seed  of  both
conventional  and transgenic  varieties in Australia.  The Company,  through its
Australian  operations,  is identifying smaller potential export markets for the
Company's products throughout  Southeast Asia. The adaptability of the Company's
germplasm must be evaluated in the target markets before such sales can be made.
The recent  instability of the economies in some of the countries in this region
will make successful market development difficult.

Employees

As of May 1,  2000,  the  Company  employed  a total of 581 full time  employees
worldwide  excluding an estimated  85  employees of joint  ventures.  Due to the
nature of the business, the Company utilizes seasonal employees in its delinting
plants and its research and  foundation  seed  programs.  The maximum  number of
seasonal employees approximates 300 and typically occurs in October and November
of each year. The Company considers its employee relations to be good.

Acquisitions

In 1996, D&PL acquired Ellis Brothers Seed, Inc., Arizona  Processing,  Inc. and
Mississippi  Seed,  Inc.,  which own the  outstanding  common stock of Sure Grow
Seed,  Inc.,  (the  "Sure  Grow  Companies")  in  exchange  for stock  valued at
approximately  $70 million on the day of  closing.  D&PL  exchanged  2.8 million
shares of its common stock (after all stock splits) for all  outstanding  shares
of the three companies.  The merger was accounted for as a pooling-of-interests.
The Company  continues to market upland picker  cottonseed  varieties  under the
Sure Grow brand. Additionally, the Sure Grow breeding program has full access to
Monsanto's Bollgard and Roundup Ready gene technologies.

In 1996, the Company acquired Hartz Cotton,  Inc. from Monsanto,  which included
inventories of cotton planting seed of Hartz upland picker varieties, germplasm,
breeding stocks,  trademarks,  trade names and other assets,  for  approximately
$6.0 million.  The consideration  consisted primarily of 1,066,666 shares (after
all stock splits) of the Company's  Series M Convertible  Non- Voting  Preferred
Stock.

In 1994,  D&PL acquired the Paymaster and Lankart cotton  planting seed business
("Paymaster"),   for  approximately   $14.0  million.   Since  the  1940's,  the
Paymaster(R)  and  Lankart(R)  upland  stripper  cottonseed  varieties have been
developed  for and  marketed  primarily in the High Plains of Texas and Oklahoma
(the  "High   Plains").   Although  the  Paymaster   varieties  are  planted  on
approximately  80% of the estimated 4.0 to 5.0 million  cotton acres in the High
Plains, only a portion of that seed is actually sold by Paymaster.  Farmer-saved
seed accounts for a significant  portion of the seed needed to plant the acreage
in this  market  area.  Prior to 1997,  the seed  needed to plant the  remaining
acreage was sold by Paymaster  and its 12 sales  associates  through a certified
seed  program.  Under this program,  Paymaster  sold parent seed to its contract
growers who  planted,  produced  and  harvested  the progeny of the parent seed,
which Paymaster then purchased from the growers.  The progeny of the parent seed
was  then  sold by  Paymaster  to the  sales  associates  who in turn  delinted,
conditioned,  bagged  and  sold  it to  others  as  certified  seed.  The  sales
associates  paid a royalty to Paymaster on  certified  seed sales.  Beginning in
fiscal 1997, the certified  seed program was  discontinued  and the Company,  in
addition to producing parent seed, commenced delinting, conditioning and bagging
finished  seed.  Unconditioned  seed is also  supplied  by D&PL to two  contract
processors  who delint,  condition and bag seed for a fee. This finished seed is
sold by Paymaster to distributors and dealers.

The Company acquired, in 1994, from the Supima Association of America ("Supima")
certain  planting seed inventory,  the right to use the Supima(R) trade name and
trademark  and the right to distribute  Pima  extra-long  staple  (fiber-length)
cotton varieties. D&PL also entered into a research agreement with a third party
to develop Pima  varieties  that allows D&PL the right of first  refusal for any
Pima varieties developed under this program. Pima seed is produced,  conditioned
and sold by D&PL to distributors and dealers.

Biotechnology

Collaborative  biotechnology  licensing  agreements,  which were  executed  with
Monsanto in 1992 and  subsequently  revised in 1993 and amended and  restated in
1996 and further amended in December 1999, provide for the  commercialization of
Monsanto's Bollgard ("Bacillus thuringiensis" or "Bt") gene technology in D&PL's
varieties in the United States.  The selected Bt is a bacterium  found naturally
in soil  and  produces  proteins  toxic  to  certain  lepidopteran  larvae,  the
principal  cotton  pests  in many  cotton  growing  areas.  Monsanto  created  a
transgenic  cotton plant by inserting  Bt genes into cotton plant  tissue.  This
transgenic  plant tissue is lethal to certain  lepidopteran  larvae that consume
it. The gene and related  technology  were  patented or licensed  from others by
Monsanto  and were  licensed to D&PL for use under the trade name  Bollgard.  In
D&PL's  primary  markets,  the  cost  of  insecticides  is  the  largest  single
expenditure  for many  cotton  growers.  The insect  resistant  capabilities  of
transgenic  cotton  containing  the  Bollgard  gene may  reduce  the  amount  of
insecticide  required  to be  applied  by cotton  growers  using  planting  seed
containing  the Bollgard  gene. In October 1995,  Monsanto was notified that the
United States Environmental  Protection Agency ("EPA") had completed its initial
registration  of the  Bollgard  gene  technology,  thus  clearing  the  way  for
commercial  sales of seed  containing  the  Bollgard  gene.  In 1996,  D&PL sold
commercially  for the first time two Deltapine  varieties,  which  contained the
Bollgard  gene,  in  accordance  with the terms of the Bollgard Gene License and
Seed  Services  Agreement  (the  "Bollgard  Agreement")  between the Company and
Monsanto.  This initial EPA  registration  expires on January 1, 2001,  at which
time the EPA will,  among other  things,  reevaluate  the  effectiveness  of the
insect resistance management plan and decide whether to convert the registration
to a non-expiring (and/or unconditional) registration.

Pursuant to the terms of the Bollgard Agreement,  farmers must buy a limited use
sublicense  for the  technology  from D&M Partners,  a  partnership  of D&PL and
Monsanto, in order to purchase seed containing the Bollgard gene technology. The
distributor/dealers  who  coordinate  the  farmer  licensing  process  receive a
service payment not to exceed 20% of the technology  sublicensing fee. After the
dealers and distributors  are compensated,  D&M Partners pays Monsanto a royalty
equal  to 71% of the net  sublicense  fee  (technology  sublicensing  fees  less
distributor/dealer  payments) and D&PL retains 29% for its services. The license
agreement  continues  until the later of the  expiration of all patent rights or
October 2008. D&M Partners  contracts the billing and collection  activities for
Bollgard and Roundup Ready licensing fees to Monsanto.

Pursuant to the Bollgard  Agreement,  Monsanto  must defend and  indemnify  D&PL
against claims of patent infringement,  including all damages awarded or amounts
paid in  settlements.  Monsanto  must also  indemnify  D&PL  against a) costs of
inventory and b) lost profits on inventory which becomes  unsaleable  because of
patent  infringement  claims.  Monsanto  must  defend  any  claims of failure of
performance of a Bollgard gene.  Monsanto and D&PL share the cost of any product
performance claims in proportion to each party's share of the royalty. Indemnity
from Monsanto only covers performance claims involving failure of performance of
the Bollgard gene and not claims arising from other causes.

D&PL has also  developed  transgenic  cotton  varieties  that  are  tolerant  to
Roundup,  a glyphosate-based  herbicide sold by Monsanto.  In 1996, such Roundup
Ready plants were approved by the Food and Drug  Administration,  the USDA,  and
the EPA. In February 1996,  the Company and Monsanto  executed the Roundup Ready
Gene License and Seed Services  Agreement (the "Roundup Ready  Agreement") which
provides for the  commercialization  of Roundup  Ready  cottonseed.  The Roundup
Ready Agreement grants a license to D&PL and certain of its affiliates the right
in the  United  States to sell  cottonseed  of  D&PL's  varieties  that  contain
Monsanto's  Roundup  Ready gene.  The  Roundup  Ready gene makes  cotton  plants
tolerant to contact with Roundup herbicide.  Similar to the Bollgard  Agreement,
farmers  must  execute  limited  use  sublicenses  in  order  to  purchase  seed
containing the Roundup Ready Gene. The  distributors/dealers  who coordinate the
farmer licensing  process receive a portion of the technology  sublicensing fee.
D&PL's  portion of the Roundup  Ready  technology  fee varies  depending  on the
technology fee per acre established by Monsanto.  In 1998 and 1999, D&M Partners
paid Monsanto  approximately  70% of the Roundup Ready  technology fees and D&PL
retained the remaining 30%.

Pursuant to the Roundup Ready Agreement, Monsanto must defend and indemnify D&PL
against claims of patent infringement,  including all damages awarded or amounts
paid in  settlements.  Monsanto  will also  indemnify  D&PL  against the cost of
inventory that becomes  unsaleable  because of patent  infringement  claims, but
Monsanto  is not  required  to  indemnify  D&PL  against  lost  profits  on such
unsaleable  seed.  In contrast  with the Bollgard Gene License where the cost of
gene  performance  claims  will be  shared  in  proportion  to the  division  of
sublicense  revenue,  Monsanto  must  defend  and must bear the full cost of any
claims of failure of performance of the Roundup Ready Gene. In both  agreements,
generally,  D&PL  is  responsible  for  varietal/seed  performance  issues,  and
Monsanto is responsible for failure of the genes.

In 2000, the Company has for sale for either commercial or experimental purposes
16 cotton planting seed varieties that contain the Bollgard gene technology,  20
cotton  planting seed varieties that contain the Roundup Ready gene  technology,
21 varieties that contain both technologies, and 50 conventional varieties.

In February  1997,  the Company and Monsanto  executed the Roundup Ready Soybean
License Agreement (the "Roundup Ready Soybean Agreement") which provides for the
commercialization  of Roundup Ready soybean seed and has  provisions  similar to
the Roundup Ready Agreement for cottonseed.

On July 27, 1999,  United States  Patent No.  5,929,300 was issued to the United
States of America as represented by the Secretary of Agriculture (USDA) entitled
POLLEN BASED  TRANSFORMATION  SYSTEM  USING SOLID  MEDIA.  D&PL has an option to
obtain a license for pollen  transformation,  subject to certain rights reserved
to the USDA. D&PL has notified the USDA of its intention to exercise its rights.
The patent covers transformation of plants.

In March 1998,  D&PL was granted  United States Patent No.  5,723,765,  entitled
CONTROL OF PLANT GENE  EXPRESSION.  This patent is owned jointly by D&PL and the
United States of America,  as represented by the Secretary of  Agriculture.  The
patent broadly covers plants and seed, both transgenic and conventional,  of all
species for a system designed to allow control of progeny seed viability without
harming  the  crop.  One  application  of the  technology  could  be to  control
unauthorized  planting of seed of proprietary varieties (sometimes called "brown
bagging") by making such practice  non-economic  since  unauthorized  saved seed
will not  germinate,  and would be  useless  for  planting.  The  patent has the
prospect of opening significant worldwide seed markets to the sale of transgenic
technology in varietal  crops in which crop seed  currently is saved and used in
subsequent  seasons as planting seed.  D&PL has stated it intends that licensing
of this technology will be made widely available to other seed companies.

Both patents were  developed  from a research  program  conducted  pursuant to a
Cooperative  Research  and  Development  Agreement  between  D&PL  and the  U.S.
Department of Agriculture's Agricultural Research Service in Lubbock, Texas. The
technologies  resulted from basic research and will require further development,
which is already  underway,  in order to be used in commercial seed. The Company
estimates  that it will be several  years  before  these  technologies  could be
available commercially.

Since  1987,  D&PL has  conducted  research  using  genes  provided by DuPont to
develop  soybean plants that are tolerant to certain  DuPont ALS(R)  herbicides.
Such plants enable farmers to apply these  herbicides  for weed control  without
significantly affecting the agronomics of the soybean plants. Since soybean seed
containing the ALS herbicide-tolerant trait was not genetically engineered, sale
of this seed does not require  government  approval,  although the  herbicide to
which they express tolerance must be EPA approved.

The Company has license, research and development,  confidentiality and material
transfer  agreements with providers of technology that the Company is evaluating
for potential  commercial  applications  and/or  introduction.  The Company also
contracts  with third parties to perform  research on the  Company's  behalf for
enabling  and  other  technologies  that the  Company  believes  have  potential
commercial applications in varietal crops around the world.

Commercial Seed

Seed of all commercial plant species is either varietal or hybrid. D&PL's cotton
and soybean seed are  varietals.  Varietal  plants can be  reproduced  from seed
produced by a parent  plant,  with the offspring  exhibiting  only minor genetic
variations.  The Plant  Variety  Protection  Act of 1970, as amended in 1994, in
essence prohibits,  with limited  exceptions,  purchasers of varieties protected
under the amended Act from selling seed harvested from these  varieties  without
permission  of the plant  variety  protection  certificate  owner.  Some foreign
countries provide similar legal protection for breeders of crop varieties.

Although  cotton is varietal  and,  therefore,  can be grown from seed of parent
plants saved by the growers,  most farmers in D&PL's  primary  domestic  markets
purchase seed from commercial  sources each season because  cottonseed  requires
delinting  prior to seed  treatment  with  chemicals  and in order to be sown by
modern planting  equipment.  Delinting and  conditioning may be done either by a
seed company on its  proprietary  seed or by independent  delinters for farmers.
Modern  cotton  farmers in upland picker areas  generally  recognize the greater
assurance of genetic purity,  quality and convenience that professionally  grown
and  conditioned  seed offers  compared  to seed they might save.  Additionally,
Federal patent law makes unlawful any  unauthorized  planting of seed containing
patented genetic technology saved from prior crops.

In connection with its seed operations,  the Company farms  approximately  2,600
acres in the U.S.,  primarily for research purposes and for production of cotton
and soybean  foundation  seed.  The Company has annual  agreements  with various
growers to produce seed for cotton and  soybeans.  The growers plant parent seed
purchased from the Company and follow quality assurance  procedures required for
seed production.  If the grower adheres to established Company quality assurance
standards  throughout the growing season and if the seed meets Company standards
upon  harvest,  the  Company may be  obligated  to  purchase  specified  minimum
quantities of seed,  usually in its first and second fiscal quarters,  at prices
equal to the  commodity  market  price of the seed  plus a grower  premium.  The
Company then conditions the seed for sale.

The  majority of the  Company's  sales are made from early in the second  fiscal
quarter  through the beginning of the fourth fiscal  quarter.  Varying  climatic
conditions can change the quarter in which seed is delivered,  thereby  shifting
sales and the  Company's  earnings  between  quarters.  Thus,  seed  production,
distribution  and sales are seasonal and interim results will not necessarily be
indicative of the Company's results for a fiscal year.

Revenues from domestic seed sales are generally recognized when seed is shipped.
Revenues from Bollgard and Roundup Ready licensing fees are recognized  based on
the  number  of acres  expected  to be  planted  with such seed when the seed is
shipped.  Prior to 1998,  licensing  fees were based on the estimated  number of
acres that farmers  represented  would be planted with the seed  purchased.  The
licensing fee charged to farmers was based on pre-established planting rates for
seven  geographic  regions in 1998 and eight such regions in 1999 and 2000,  and
the  estimated  number of seed  contained in each bag which may vary by variety,
location  grown,  and  other  factors.   Revenue  is  recognized  based  on  the
established   technology  fee  per  unit  shipped  to  each  geographic  region.
Domestically,  the  Company  promotes  its cotton and soybean  seed  directly to
farmers  and  sells  its  seed  through  distributors  and  dealers.  All of the
Company's  domestic  seed  products   (including   Bollgard  and  Roundup  Ready
technologies) are subject to return or credit, which vary from year to year. The
annual level of returns and,  ultimately,  net sales are  influenced  by various
factors,  principally  commodity prices and weather conditions  occurring in the
spring  planting  season during the  Company's  third and fourth  quarters.  The
Company  provides for  estimated  returns as sales occur.  To the extent  actual
returns differ from estimates,  adjustments to the Company's  operating  results
are recorded  when such  differences  become  known,  typically in the Company's
fourth  quarter.  All  significant  returns occur or are accounted for by fiscal
year end.  International  export  revenues are recognized upon the later of when
seed is  shipped  or the  date  letters  of  credit  are  confirmed.  Generally,
international  export sales are not subject to return.  All other  international
revenues from the sale of planting seed,  less  estimated  reserves for returns,
are recognized when the seed is shipped.

Euro Currency Conversion

On January 1, 1999,  the euro became the common  legal  currency of 11 of the 15
member  countries  of the  European  Union.  On  that  date,  the  participating
countries fixed  conversion  rates between their sovereign  currencies  ("legacy
currencies")  and the euro.  On  January  4,  1999,  the euro  began  trading on
currency  exchanges and became available for non-cash  transactions.  The legacy
currencies will remain legal tender through December 31, 2001. Beginning January
2, 2002,  euro-denominated  bills and coins will be  introduced,  and by July 1,
2002,  legacy  currencies will no longer be legal tender.  To date, D&PL has not
been affected by the euro currency conversion.

Year 2000 Readiness Disclosure

Beginning in 1996,  D&PL  initiated  its Global Year 2000 program to ensure that
its infrastructure and information systems comply with the systems  requirements
for the year 2000.  D&PL  essentially  completed  the  program.  The majority of
systems,   including   critical   business   systems,   comply  with  year  2000
requirements,  due in large part to the  installation  in fiscal 1997 of a third
party software system that was year 2000 compliant,  at a cost in excess of $3.0
million. While the year 2000 efforts involved additional costs, D&PL was able to
manage its in-house year 2000  transition  issues  without any material  adverse
effect on its business operations or financial position.  Total cost incurred to
date for year 2000 considerations  (excluding third party software)  approximate
$600,000  and the Company  estimates  that no  additional  funds are required to
complete the year 2000 compliance process.

D&PL  also  contacted  its  major   suppliers  and  customers  to  assess  their
preparations  for the year 2000.  These  actions were taken to help mitigate the
possible external impact of year 2000 issues. It is not feasible to fully assess
the potential  consequences if D&PL's customers are not compliant.  D&M Partners
(a  partnership  of which D&PL owns 90% and Monsanto  owns 10%)  contracts  with
Monsanto to i) administer  sublicensing to farmers the right to use the Bollgard
and Roundup Ready technologies, ii) bill for such technologies, and iii) collect
the sublicensing revenues for using technology. Monsanto disclosed that all year
2000  remediation  work for its internal systems would be completed by the third
calendar quarter of 1999. The Company is not able to predict at the present time
the impact,  if any, on its business if Monsanto is unable to resolve any of its
remaining year 2000 issues.

D&PL's  discussion  of the year 2000  computer  issue  contains  forward-looking
information.   D&PL  believes  that  its  critical  computer  systems  are  year
2000-compliant.  Nevertheless, factors that could cause actual results to differ
from the Company's  expectations  include the successful  implementation of year
2000 initiatives by its customers and suppliers, changes in the availability and
cost of resources  to implement  any year 2000  changes,  and D&PL's  ability to
successfully identify and correct all systems affected by the year 2000 issue.

Outlook

From time to time, the Company may make  forward-looking  statements relating to
such matters as anticipated financial performance,  existing products, technical
developments,  new  products,  research and  development  activities,  year 2000
issues and similar matters. The Private Securities Litigation Reform Act of 1995
provides a safe harbor for forward-looking  statements.  In order to comply with
the terms of the safe harbor,  the Company notes that a variety of factors could
cause the Company's actual results and experience to differ  materially from the
anticipated   results  or  other   expectations   expressed  in  the   Company's
forward-looking  statements.  The risks and  uncertainties  that may  affect the
operations,  performance,  development  and  results of the  Company's  business
include those noted elsewhere in this Item and the following:

      Demand  for  D&PL's  seed will be  affected  by  government  programs  and
      policies  and  most  importantly,  by  weather.  Demand  for  seed is also
      influenced by commodity  prices and the demand for a crop's  end-uses such
      as textiles, animal feed, food and raw materials for industrial use. These
      factors,  along with weather,  influence the cost and availability of seed
      for subsequent seasons.  Weather impacts crop yields, commodity prices and
      the planting  decisions that farmers make regarding both original planting
      commitments and, when necessary, replanting levels.

      The planting seed market is highly  competitive,  and D&PL  varieties face
      competition  from  a  number  of  seed  companies,   diversified  chemical
      companies, agricultural biotechnology companies, governmental agencies and
      academic   and   scientific   institutions.   A  number  of  chemical  and
      biotechnology   companies  have  seed   production   and/or   distribution
      capabilities  to  ensure  market  access  for new  seed  products  and new
      technologies  that may compete with the  Bollgard  and Roundup  Ready gene
      technologies.  The  Company's  seed  products and  technologies  contained
      therein may encounter substantial  competition from technological advances
      by others or  products  from new market  entrants.  Many of the  Company's
      competitors are, or are affiliated with, large diversified  companies that
      have substantially greater resources than the Company.

      The production, distribution or sale of crop seed in or to foreign markets
      may be  subject  to  special  risks,  including  fluctuations  in  foreign
      currency, exchange rate controls, expropriation, nationalization and other
      agricultural,   economic,   tax  and   regulatory   policies   of  foreign
      governments.  Particular  policies  which  may  affect  the  domestic  and
      international  operations of D&PL include the use of and the acceptance of
      products that were produced  from plants that were  genetically  modified,
      the testing,  quarantine and other restrictions relating to the import and
      export of plants and seed products and the  availability (or lack thereof)
      of proprietary  protection for plant products. In addition,  United States
      government  policies,  particularly  those  affecting  foreign  trade  and
      investment, may impact the Company's international operations.

      The recent publicity related to genetically  modified organisms  ("GMO's")
      or products  made from plants that contain GMO's may have an effect on the
      Company's sales in the future. In 2000, approximately 85% of the Company's
      cotton seed that was sold contained either the Bollgard, Roundup Ready, or
      both  gene  technologies  and  69% of the  Company's  soybean  seed  sales
      contained  the Roundup Ready gene  technology.  Although many farmers have
      rapidly  adopted  these  technologies,  the alleged  concern over finished
      products that contain GMO's could impact demand for crops raised from seed
      containing such traits.

      Due to the varying levels of  agricultural  and social  development of the
      international markets in which the Company operates and because of factors
      within the  particular  international  markets  targeted  by the  Company,
      international  profitability and growth may be less stable and predictable
      than domestic profitability and growth.

      Overall  profitability  will depend on the factors  noted above as well as
      weather conditions, government policies in all countries where the Company
      sells products and operates,  worldwide  commodity  prices,  the Company's
      ability to  successfully  open new  international  markets,  the Company's
      ability  to  successfully  continue  the  development  of the High  Plains
      market,  the  technology  partners'  ability to obtain  timely  government
      approval  (and maintain  such  approval)  for existing and for  additional
      biotechnology  products  on which they and the Company are working and the
      Company's  ability to produce  sufficient  commercial  quantities  of high
      quality  planting  seed of these  products.  Any delay in or  inability to
      successfully complete these projects may affect future profitability.

Item 6.  Exhibits and Reports on Form 8-K

 (a) Exhibits.

     11.01  Reconciliation of the Basic and Diluted Per Share  Computations  for
          Income  Before  the  Cumulative  Effect  of  a  Change  in  Accounting
          Principle as Required by SFAS 128 Paragraph 40(a)

     27.01 Financial Data Schedule

(b) Reports on Form 8-K.

On May 18, 2000 the  Company  filed Form 8-K dated  December 8, 1999,  regarding
amendments  to the  February 2, 1996  Bollgard  Gene  License and Seed  Services
Agreement  and the February 2, 1996 Roundup Ready Gene License and Seed Services
Agreement among D&PL, D&M Partners and Monsanto Company and the February 2, 1996
Option Agreement between D&PL and Monsanto and the February 2, 1996 Hartz Cotton
Acquisition  Agreement  among  Monsanto,  Hartz Cotton Inc.,  D&PL and Paymaster
Technology Corp. (a wholly owned subsidiary of D&PL).



                                   SIGNATURES

Pursuant to the  requirements  of the  Securities  and Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.

                                                    DELTA AND PINE LAND COMPANY


Date:     July 14, 2000                             /s/ Roger D. Malkin
                                                    -------------------
                                                    Roger D. Malkin, Chairman
                                                    and Chief Executive Officer

Date:     July 14, 2000                             /s/ W. Thomas Jagodinski
                                                    ------------------------
                                                    W. Thomas Jagodinski,
                                                    Vice President - Finance
                                                        and Treasurer





<PAGE>


                                  Exhibit 11.01

       RECONCILIATION OF THE BASIC AND DILUTED PER SHARE COMPUTATIONS FOR
          INCOME BEFORE THE CUMULATIVE EFFECT OF A CHANGE IN ACCOUNTING
                PRINCIPLE AS REQUIRED BY SFAS 128 PARAGRAPH 40(a)
<TABLE>
<CAPTION>

                                                                          For the Three Months Ended May 31,
                                              --------------------------------------------------------------------------------------
                                                                1999                                          2000
                                              -----------------------------------           ----------------------------------------
                                                                        Per Share                                          Per Share
                                                Income       Shares       Amount              Income         Shares         Amount
                                                ------       ------       ------              ------         ------         ------
<S>                                             <C>             <C>         <C>                 <C>             <C>             <C>
Income before cumulative effect of
         accounting change                    $ 20,748                                      $ 34,888
Less:  Preferred Stock Dividends                   (24)                                          (32)
                                              --------                                      --------
Basic EPS:
Income available to common stockholders         20,724       38,454    $    0.54              34,856         38,319        $    0.91
                                                             ------    =========                             ------        =========
Effect of Dilutive Securities:
Common Stock Equivalents                                      1,497                                             459
Convertible Preferred Stock                         24        1,067                               32          1,067
                                              --------       ------                         --------         ------
                                                              2,564                                           1,526
                                                             ------                                          ------
Diluted EPS:
Income available to common stockholders
         plus assumed conversions               20,748       41,018    $    0.51              34,888         39,845        $    0.88
                                                ======       ======    =========              ======         ======        =========


                                                                          For the Nine Months Ended May 31,
                                              --------------------------------------------------------------------------------------
                                                                1999                                          2000
                                              -----------------------------------           ----------------------------------------
                                                                        Per Share                                          Per Share
                                                Income       Shares       Amount              Income         Shares         Amount
                                                ------       ------       ------              ------         ------         ------
Income before cumulative effect of
accounting change                             $ 16,716                                      $ 86,972
Less:  Preferred Stock Dividends                   (72)                                          (96)
                                              --------                                      --------
Basic EPS:
Income available to common stockholders         16,644       38,415    $    0.43              86,876         38,541        $    2.25
                                                             ------    =========                             ------        =========
Effect of Dilutive Securities:
Common Stock Equivalents                                      1,595                                             549
Convertible Preferred Stock                         72        1,067                               96          1,067
                                              --------       ------                         --------         ------
                                                              2,662                                           1,616
                                                             ------                                          ------
Diluted EPS:
Income available to common stockholders
plus assumed conversions                        16,716       41,077    $    0.41              86,972         40,157        $    2.16
                                                ======       ======    =========              ======         ======        =========
</TABLE>




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission